BnR Summit 2026

Belt & Road Summit - Deal-Making 2026

9 – 15 Sept 2026 | Hong Kong, China (Hong Kong)

Register
Register
Register

Qi Diagnostics Limited

www.qidiagnostics.comChina (Hong Kong)
5 profile visits

About

We are developing a Next Generation Cancer Detection Breathalyzer. It can perform multiple cancers screening and lung cancer specific detection.

We also have a novel handheld breath testing device for cannabis and drug detection.

我们正在研发下一代癌症检测呼气分析仪。可进行多种癌症筛查和肺癌特异性检测。

我们还开发了一种新型的手持呼气测试设备,用于大麻和毒品检测。

Technology

Health TechnologyMedical Technology

Additional Information

Other Place of Business

Hong KongMainland China

Company Funding Stage

Seed & Pre-Series

Terms and Conditions & Disclaimer

I agree

Representatives

Founder & CEO

Qi Diagnostics Limited

Marketplace (2)

  • Project

    Point-of-care Early Cancer Breath Testing

    We are proud to be the first team to develop a cancer-specific breath marker and a POC breathalyzer device with high sensitivity and promising clinical applicability in detecting cancer tumors.

    • No
    • Yes
    • Debt
    • Equity
    • Technology
    • Private Project
    • Health Technology
    • Convertible Loan
    • Equity (private)
    • Medical Technology
    • Financial Services
    • Open for negotiation
    • Open for Negotiation
    • Minority Shareholdings
    • Direct Equity Investment
    • Institutional Investment
    • 2,500,001 to 5,000,000 USD
    • Public / Alternative Financing
    • Private Equity & Venture Capital
    • Investment / Financing Discussion
    Author

    Founder & CEO at Qi Diagnostics Limited

    China (Hong Kong)

  • Project

    Cannabis and Drug Breath Testing

    A novel handheld breath analyzer for cannabis and drug detection.

    • No
    • Yes
    • Debt
    • Equity
    • Technology
    • Joint Venture
    • Private Project
    • Health Technology
    • Convertible Loan
    • Equity (private)
    • Medical Technology
    • Financial Services
    • Open for negotiation
    • Open for Negotiation
    • Professional Services
    • 500,001 to 1,000,000 USD
    • Direct Equity Investment
    • Institutional Investment
    • Feasibility Study Completed
    • Public / Alternative Financing
    • Market Entry Strategic Analysis
    • Private Equity & Venture Capital
    • Public–private partnership / Concession
    Author

    Founder & CEO at Qi Diagnostics Limited

    China (Hong Kong)